Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Clinical trial NCT02945176 · COMPLETED

Trial details

NCT number: NCT02945176
Sponsor: Implandata Ophthalmic Products GmbH
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Graft vs Host Disease Congenital Aniridia Chemical Burns Stevens-Johnson Syndrome Congenital Glaucoma

Start date: 2015-03-01
Primary completion: 2017-06-14
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.